₩6550.00
₩-170.00 (-2.53%)
End-of-day quote: 05/17/2024
KOSE:A003000
Bukwang Pharmaceutical Annual Report
| Year | Year | 2023 | 2015 | 2012 | ||
|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩125.93B | ₩142.13B | ₩147.53B | |
| GM % | Gross Margin % |
|
37.26% | 58.04% | 53.95% | |
| OM | Operating Margin |
|
-29.78% | 16.38% | 14.53% | |
| EPS | Earnings Per Share |
|
₩0.00 | ₩389.00 | ₩389.00 | ₩245.82 |
| Div. | Dividends |
|
₩294.32 | ₩294.32 | ₩0.00 | |
| PR % | Payout Ratio % |
|
75.66% | 75.66% | 0 | |
| Sha. | Shares |
|
68.45m | 64.59m | 55.06m | |
| OCF | Operating Cash Flow |
|
₩-9361.82M | ₩10.30B | ₩49.50B | |
| FCF | Free Cash Flow |
|
₩-12196.49M | ₩5.72B | ₩47.74B | |
| FCFS | Free Cash Flow Per Share |
|
₩-174.26 | ₩94.90 | ₩700.40 |
